Author(s): Woodcock J
Abstract Share this page
Abstract As the pharmaceutical industry productivity crisis worsens, there are calls for regulatory changes to support innovation. At the same time, prescribers and payers desire more information about drugs at the time they are released to the market. Will new regulatory schemes be able to accommodate these disparate needs?
This article was published in Clin Pharmacol Ther
and referenced in Journal of Microbial & Biochemical Technology